Last Price
0.007
Today's Change
+0.001 (16.66%)
Day's Change
0.007 - 0.007
Trading Volume
86,250,681
Overview
Market Cap
37 Million
Shares Outstanding
5 Billion
Avg Volume
10,248,463
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
-0.70
EPS
-0.01
Earnings Announcement
03-Feb-2025
Previous Close
0.01
Open
0.01
Day's Range
0.007 - 0.007
Year Range
0.002 - 0.008
Trading Volume
86,250,681
Price Change Highlight
1 Day Change
16.67%
5 Day Change
16.67%
1 Month Change
133.33%
3 Month Change
75.00%
6 Month Change
75.00%
Ytd Change
0.00%
1 Year Change
0.00%
3 Year Change
-68.18%
5 Year Change
-73.08%
10 Year Change
-96.67%
Max Change
-98.60%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
